Published in Acta Psychiatr Scand on March 15, 2014
Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis. Mol Psychiatry (2015) 0.93
Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence. Can J Psychiatry (2014) 0.90
Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast (2014) 0.83
Hippocampal volume and verbal memory performance in late-stage bipolar disorder. J Psychiatr Res (2015) 0.82
Discrimination between Alzheimer's Disease and Late Onset Bipolar Disorder Using Multivariate Analysis. Front Aging Neurosci (2015) 0.78
Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder. Int J Neuropsychopharmacol (2014) 0.78
Changes in the corpus callosum in women with late-stage bipolar disorder. Acta Psychiatr Scand (2015) 0.78
Early interventions for youths at high risk for bipolar disorder: a developmental approach. Eur Child Adolesc Psychiatry (2015) 0.76
Mental disorders, functional impairment, and nerve growth factor. Psychol Res Behav Manag (2016) 0.75
Neurobiology of Risk for Bipolar Disorder. Curr Treat Options Psychiatry (2016) 0.75
Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry (2017) 0.75
White Matter Tract Integrity in Alzheimer's Disease vs. Late Onset Bipolar Disorder and Its Correlation with Systemic Inflammation and Oxidative Stress Biomarkers. Front Aging Neurosci (2017) 0.75
The bipolar-borderline personality disorders connection in major depressive patients. Acta Psychiatr Scand (2013) 3.12
Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord (2004) 2.21
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl (2007) 2.12
Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration? J Psychopharmacol (2008) 2.07
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev (2010) 1.99
Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry (2009) 1.97
Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord (2007) 1.65
Increased serum S100B protein in schizophrenia: a study in medication-free patients. J Psychiatr Res (2001) 1.62
Risk factors for suicide in schizophrenia: systematic review and clinical recommendations. Acta Psychiatr Scand (2014) 1.54
Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand (2013) 1.52
Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand (2011) 1.52
"Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorder. Acta Psychiatr Scand (2013) 1.50
Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatr Scand (2011) 1.47
Neuropsychological and psychiatric complications in endoscopic third ventriculostomy: a clinical case report. J Neurol Neurosurg Psychiatry (2001) 1.42
Delayed cervical anastomosis of the esophagus for esophageal carcinoma. Int Surg (1997) 1.40
Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom (2009) 1.37
Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry (2000) 1.35
Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol Med (2012) 1.25
Identifying and improving non-adherence in bipolar disorders. Bipolar Disord (2005) 1.24
Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am (2005) 1.21
Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci (2011) 1.20
Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord (2009) 1.17
Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord (2006) 1.15
Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom (2000) 1.11
Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother Psychosom (2001) 1.10
Treatment guidelines for bipolar disorder: a critical review. J Affect Disord (2005) 1.08
Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity. Eur Arch Psychiatry Clin Neurosci (2013) 1.08
Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant (1996) 1.05
Impact of a psychoeducational family intervention on caregivers of stabilized bipolar patients. Psychother Psychosom (2004) 1.04
Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels. Bipolar Disord (2005) 1.03
Mania associated with an energy drink: the possible role of caffeine, taurine, and inositol. Can J Psychiatry (2001) 1.00
Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand (2014) 0.99
Predominant polarity in bipolar disorder: diagnostic implications. J Affect Disord (2007) 0.99
Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom (2005) 0.99
Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand (2013) 0.98
A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry (2010) 0.98
Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study. Acta Psychiatr Scand (2013) 0.98
Treatment-resistant bipolar depression: towards a new definition. Acta Psychiatr Scand (2009) 0.97
Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. Acta Psychiatr Scand (2008) 0.97
Purinergic dysfunction in mania: an integrative model. Med Hypotheses (2002) 0.97
Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord (2007) 0.96
Variability in the serotonin transporter gene and increased risk for major depression with melancholia. Hum Genet (1998) 0.94
Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study. Acta Psychiatr Scand (2006) 0.94
Comparative pharmacological study of hydroethanol extracts of Passiflora alata and Passiflora edulis leaves. Phytother Res (2001) 0.94
The road to DSM-V. Bipolar disorder episode and course specifiers. Psychopathology (2009) 0.93
Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. J Affect Disord (2009) 0.93
Therapeutic efficacy of allopurinol in mania associated with hyperuricemia. J Clin Psychopharmacol (2001) 0.93
Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe. J Psychiatr Res (2008) 0.92
Onset-age of bipolar disorders at six international sites. J Affect Disord (2009) 0.92
Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview. Acta Psychiatr Scand (2012) 0.91
Functional impairment in patients with remitted bipolar disorder. Psychother Psychosom (2008) 0.91
One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr Scand (2012) 0.91
Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels. Neuroscience (2010) 0.91
Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany. J Affect Disord (2012) 0.90
Impulsivity and functional impairment in bipolar disorder. J Affect Disord (2011) 0.89
Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences. Eur Psychiatry (2001) 0.89
Stigma and functioning in patients with bipolar disorder. J Affect Disord (2010) 0.89
Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis. J Affect Disord (2008) 0.89
Mirtazapine versus fluoxetine in the treatment of panic disorder. Braz J Med Biol Res (2001) 0.89
Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability. J Affect Disord (2011) 0.87
Functional impairment in bipolar II disorder: is it as disabling as bipolar I? J Affect Disord (2010) 0.87
Are bipolar II patients cognitively impaired? A systematic review. Psychol Med (2011) 0.87
What really matters to bipolar patients' caregivers: sources of family burden. J Affect Disord (2006) 0.86
Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Mol Psychiatry (2007) 0.86
Treatment of refractory rapid cycling bipolar disorder with risperidone. J Clin Psychopharmacol (1998) 0.86
The clinical implications of cognitive impairment and allostatic load in bipolar disorder. Eur Psychiatry (2012) 0.85
Neurocognitive impairment across the bipolar spectrum. CNS Neurosci Ther (2011) 0.85
Treatment adherence in bipolar I and schizoaffective disorder, bipolar type. J Affect Disord (2013) 0.85
A bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 years. Psychopathology (2008) 0.85
Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Eur Neuropsychopharmacol (2002) 0.85
Antidepressant-induced mania in obsessive-compulsive disorder. Am J Psychiatry (1992) 0.85
Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects. Acta Psychiatr Scand (2007) 0.85
Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology. Acta Psychiatr Scand (2009) 0.84
2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery. Eur Neuropsychopharmacol (2010) 0.84
Clinical and prognostic implications of seasonal pattern in bipolar disorder: a 10-year follow-up of 302 patients. Psychol Med (2007) 0.84
Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series. J Psychopharmacol (2008) 0.84
The impact of repeated manic episodes and executive dysfunction on work adjustment in bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2013) 0.84
Depression subtypes in bipolar I and II disorders. Psychopathology (2007) 0.84
Serum transferrin and serum prealbumin as markers of response to nutritional support in patients with esophageal cancer. Nutr Hosp (2009) 0.83
In-patient care costs of patients with bipolar I disorder: a comparison between two European centers. J Affect Disord (2009) 0.83
Neuropsychological performance in depressed and euthymic bipolar patients. Neuropsychobiology (2002) 0.83
Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study. Actas Esp Psiquiatr (2007) 0.83
Brain functional abnormality in schizo-affective disorder: an fMRI study. Psychol Med (2012) 0.83
The CACNA1C risk allele selectively impacts on executive function in bipolar type I disorder. Acta Psychiatr Scand (2013) 0.82
Isolation of Histoplasma capsulatum from bats in the urban area of São Paulo State, Brazil. Epidemiol Infect (2010) 0.82
Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder. Bipolar Disord (2008) 0.82
Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Acta Psychiatr Scand (2011) 0.82